TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Anti-Neprilysin Market Insights, Forecast to 2028

Global Anti-Neprilysin Market Insights, Forecast to 2028

  • Category:Life Sciences
  • Published on : 03 August 2022
  • Pages :93
  • Formats:
  • Report Code:SMR-7252006
OfferClick for best price

Best Price: $3920

AntiNeprilysin Market Size, Share 2022


Market Analysis and Insights: Global AntiNeprilysin Market

The global AntiNeprilysin market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global AntiNeprilysin market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global AntiNeprilysin market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global AntiNeprilysin market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global AntiNeprilysin market.

Global AntiNeprilysin Scope and Market Size

Anti-Neprilysin market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Anti-Neprilysin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Sacubitril

TD-0714

STR-324

PL-265

LHW-090

Segment by Application

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Company

Bioprojet SCR

Novartis International AG

Pharmaleads SA

Theravance Biopharma Inc.

Cipla Limited

Oceanic Pharmachem Pvt. Ltd

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes AntiNeprilysin product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of AntiNeprilysin, with price, sales, revenue, and global market share of AntiNeprilysin from 2019 to 2022.

Chapter 3, the AntiNeprilysin competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the AntiNeprilysin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the AntiNeprilysin market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of AntiNeprilysin.

Chapter 13, 14, and 15, to describe AntiNeprilysin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 AntiNeprilysin Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Anti-Neprilysin Market Insights, Forecast to 2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 93 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-Neprilysin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Sacubitril
1.2.3 TD-0714
1.2.4 STR-324
1.2.5 PL-265
1.2.6 LHW-090
1.3 Market by Application
1.3.1 Global Anti-Neprilysin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anti-Neprilysin Market Perspective (2017-2028)
2.2 Anti-Neprilysin Growth Trends by Region
2.2.1 Anti-Neprilysin Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Anti-Neprilysin Historic Market Size by Region (2017-2022)
2.2.3 Anti-Neprilysin Forecasted Market Size by Region (2023-2028)
2.3 Anti-Neprilysin Market Dynamics
2.3.1 Anti-Neprilysin Industry Trends
2.3.2 Anti-Neprilysin Market Drivers
2.3.3 Anti-Neprilysin Market Challenges
2.3.4 Anti-Neprilysin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-Neprilysin Players by Revenue
3.1.1 Global Top Anti-Neprilysin Players by Revenue (2017-2022)
3.1.2 Global Anti-Neprilysin Revenue Market Share by Players (2017-2022)
3.2 Global Anti-Neprilysin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti-Neprilysin Revenue
3.4 Global Anti-Neprilysin Market Concentration Ratio
3.4.1 Global Anti-Neprilysin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-Neprilysin Revenue in 2021
3.5 Anti-Neprilysin Key Players Head office and Area Served
3.6 Key Players Anti-Neprilysin Product Solution and Service
3.7 Date of Enter into Anti-Neprilysin Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-Neprilysin Breakdown Data by Type
4.1 Global Anti-Neprilysin Historic Market Size by Type (2017-2022)
4.2 Global Anti-Neprilysin Forecasted Market Size by Type (2023-2028)
5 Anti-Neprilysin Breakdown Data by Application
5.1 Global Anti-Neprilysin Historic Market Size by Application (2017-2022)
5.2 Global Anti-Neprilysin Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Anti-Neprilysin Market Size (2017-2028)
6.2 North America Anti-Neprilysin Market Size by Type
6.2.1 North America Anti-Neprilysin Market Size by Type (2017-2022)
6.2.2 North America Anti-Neprilysin Market Size by Type (2023-2028)
6.2.3 North America Anti-Neprilysin Market Share by Type (2017-2028)
6.3 North America Anti-Neprilysin Market Size by Application
6.3.1 North America Anti-Neprilysin Market Size by Application (2017-2022)
6.3.2 North America Anti-Neprilysin Market Size by Application (2023-2028)
6.3.3 North America Anti-Neprilysin Market Share by Application (2017-2028)
6.4 North America Anti-Neprilysin Market Size by Country
6.4.1 North America Anti-Neprilysin Market Size by Country (2017-2022)
6.4.2 North America Anti-Neprilysin Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Anti-Neprilysin Market Size (2017-2028)
7.2 Europe Anti-Neprilysin Market Size by Type
7.2.1 Europe Anti-Neprilysin Market Size by Type (2017-2022)
7.2.2 Europe Anti-Neprilysin Market Size by Type (2023-2028)
7.2.3 Europe Anti-Neprilysin Market Share by Type (2017-2028)
7.3 Europe Anti-Neprilysin Market Size by Application
7.3.1 Europe Anti-Neprilysin Market Size by Application (2017-2022)
7.3.2 Europe Anti-Neprilysin Market Size by Application (2023-2028)
7.3.3 Europe Anti-Neprilysin Market Share by Application (2017-2028)
7.4 Europe Anti-Neprilysin Market Size by Country
7.4.1 Europe Anti-Neprilysin Market Size by Country (2017-2022)
7.4.2 Europe Anti-Neprilysin Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-Neprilysin Market Size (2017-2028)
8.2 Asia-Pacific Anti-Neprilysin Market Size by Type
8.2.1 Asia-Pacific Anti-Neprilysin Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Anti-Neprilysin Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Anti-Neprilysin Market Share by Type (2017-2028)
8.3 Asia-Pacific Anti-Neprilysin Market Size by Application
8.3.1 Asia-Pacific Anti-Neprilysin Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Anti-Neprilysin Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Anti-Neprilysin Market Share by Application (2017-2028)
8.4 Asia-Pacific Anti-Neprilysin Market Size by Region
8.4.1 Asia-Pacific Anti-Neprilysin Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Anti-Neprilysin Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anti-Neprilysin Market Size (2017-2028)
9.2 Latin America Anti-Neprilysin Market Size by Type
9.2.1 Latin America Anti-Neprilysin Market Size by Type (2017-2022)
9.2.2 Latin America Anti-Neprilysin Market Size by Type (2023-2028)
9.2.3 Latin America Anti-Neprilysin Market Share by Type (2017-2028)
9.3 Latin America Anti-Neprilysin Market Size by Application
9.3.1 Latin America Anti-Neprilysin Market Size by Application (2017-2022)
9.3.2 Latin America Anti-Neprilysin Market Size by Application (2023-2028)
9.3.3 Latin America Anti-Neprilysin Market Share by Application (2017-2028)
9.4 Latin America Anti-Neprilysin Market Size by Country
9.4.1 Latin America Anti-Neprilysin Market Size by Country (2017-2022)
9.4.2 Latin America Anti-Neprilysin Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-Neprilysin Market Size (2017-2028)
10.2 Middle East & Africa Anti-Neprilysin Market Size by Type
10.2.1 Middle East & Africa Anti-Neprilysin Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Anti-Neprilysin Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Anti-Neprilysin Market Share by Type (2017-2028)
10.3 Middle East & Africa Anti-Neprilysin Market Size by Application
10.3.1 Middle East & Africa Anti-Neprilysin Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Anti-Neprilysin Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Anti-Neprilysin Market Share by Application (2017-2028)
10.4 Middle East & Africa Anti-Neprilysin Market Size by Country
10.4.1 Middle East & Africa Anti-Neprilysin Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Anti-Neprilysin Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bioprojet SCR
11.1.1 Bioprojet SCR Company Details
11.1.2 Bioprojet SCR Business Overview
11.1.3 Bioprojet SCR Anti-Neprilysin Introduction
11.1.4 Bioprojet SCR Revenue in Anti-Neprilysin Business (2017-2022)
11.1.5 Bioprojet SCR Recent Developments
11.2 Novartis International AG
11.2.1 Novartis International AG Company Details
11.2.2 Novartis International AG Business Overview
11.2.3 Novartis International AG Anti-Neprilysin Introduction
11.2.4 Novartis International AG Revenue in Anti-Neprilysin Business (2017-2022)
11.2.5 Novartis International AG Recent Developments
11.3 Pharmaleads SA
11.3.1 Pharmaleads SA Company Details
11.3.2 Pharmaleads SA Business Overview
11.3.3 Pharmaleads SA Anti-Neprilysin Introduction
11.3.4 Pharmaleads SA Revenue in Anti-Neprilysin Business (2017-2022)
11.3.5 Pharmaleads SA Recent Developments
11.4 Theravance Biopharma Inc.
11.4.1 Theravance Biopharma Inc. Company Details
11.4.2 Theravance Biopharma Inc. Business Overview
11.4.3 Theravance Biopharma Inc. Anti-Neprilysin Introduction
11.4.4 Theravance Biopharma Inc. Revenue in Anti-Neprilysin Business (2017-2022)
11.4.5 Theravance Biopharma Inc. Recent Developments
11.5 Cipla Limited
11.5.1 Cipla Limited Company Details
11.5.2 Cipla Limited Business Overview
11.5.3 Cipla Limited Anti-Neprilysin Introduction
11.5.4 Cipla Limited Revenue in Anti-Neprilysin Business (2017-2022)
11.5.5 Cipla Limited Recent Developments
11.6 Oceanic Pharmachem Pvt. Ltd
11.6.1 Oceanic Pharmachem Pvt. Ltd Company Details
11.6.2 Oceanic Pharmachem Pvt. Ltd Business Overview
11.6.3 Oceanic Pharmachem Pvt. Ltd Anti-Neprilysin Introduction
11.6.4 Oceanic Pharmachem Pvt. Ltd Revenue in Anti-Neprilysin Business (2017-2022)
11.6.5 Oceanic Pharmachem Pvt. Ltd Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Anti-Neprilysin Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Sacubitril
Table 3. Key Players of TD-0714
Table 4. Key Players of STR-324
Table 5. Key Players of PL-265
Table 6. Key Players of LHW-090
Table 7. Global Anti-Neprilysin Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Anti-Neprilysin Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Anti-Neprilysin Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Anti-Neprilysin Market Share by Region (2017-2022)
Table 11. Global Anti-Neprilysin Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Anti-Neprilysin Market Share by Region (2023-2028)
Table 13. Anti-Neprilysin Market Trends
Table 14. Anti-Neprilysin Market Drivers
Table 15. Anti-Neprilysin Market Challenges
Table 16. Anti-Neprilysin Market Restraints
Table 17. Global Anti-Neprilysin Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Anti-Neprilysin Revenue Share by Players (2017-2022)
Table 19. Global Top Anti-Neprilysin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Neprilysin as of 2021)
Table 20. Ranking of Global Top Anti-Neprilysin Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Anti-Neprilysin Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Anti-Neprilysin Product Solution and Service
Table 24. Date of Enter into Anti-Neprilysin Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Anti-Neprilysin Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Anti-Neprilysin Revenue Market Share by Type (2017-2022)
Table 28. Global Anti-Neprilysin Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Anti-Neprilysin Revenue Market Share by Type (2023-2028)
Table 30. Global Anti-Neprilysin Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Anti-Neprilysin Revenue Share by Application (2017-2022)
Table 32. Global Anti-Neprilysin Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Anti-Neprilysin Revenue Share by Application (2023-2028)
Table 34. North America Anti-Neprilysin Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Anti-Neprilysin Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Anti-Neprilysin Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Anti-Neprilysin Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Anti-Neprilysin Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Anti-Neprilysin Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Anti-Neprilysin Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Anti-Neprilysin Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Anti-Neprilysin Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Anti-Neprilysin Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Anti-Neprilysin Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Anti-Neprilysin Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Anti-Neprilysin Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Anti-Neprilysin Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Anti-Neprilysin Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Anti-Neprilysin Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Anti-Neprilysin Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Anti-Neprilysin Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Anti-Neprilysin Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Anti-Neprilysin Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Anti-Neprilysin Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Anti-Neprilysin Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Anti-Neprilysin Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Anti-Neprilysin Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Anti-Neprilysin Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Anti-Neprilysin Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Anti-Neprilysin Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Anti-Neprilysin Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Anti-Neprilysin Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Anti-Neprilysin Market Size by Country (2023-2028) & (US$ Million)
Table 64. Bioprojet SCR Company Details
Table 65. Bioprojet SCR Business Overview
Table 66. Bioprojet SCR Anti-Neprilysin Product
Table 67. Bioprojet SCR Revenue in Anti-Neprilysin Business (2017-2022) & (US$ Million)
Table 68. Bioprojet SCR Recent Developments
Table 69. Novartis International AG Company Details
Table 70. Novartis International AG Business Overview
Table 71. Novartis International AG Anti-Neprilysin Product
Table 72. Novartis International AG Revenue in Anti-Neprilysin Business (2017-2022) & (US$ Million)
Table 73. Novartis International AG Recent Developments
Table 74. Pharmaleads SA Company Details
Table 75. Pharmaleads SA Business Overview
Table 76. Pharmaleads SA Anti-Neprilysin Product
Table 77. Pharmaleads SA Revenue in Anti-Neprilysin Business (2017-2022) & (US$ Million)
Table 78. Pharmaleads SA Recent Developments
Table 79. Theravance Biopharma Inc. Company Details
Table 80. Theravance Biopharma Inc. Business Overview
Table 81. Theravance Biopharma Inc. Anti-Neprilysin Product
Table 82. Theravance Biopharma Inc. Revenue in Anti-Neprilysin Business (2017-2022) & (US$ Million)
Table 83. Theravance Biopharma Inc. Recent Developments
Table 84. Cipla Limited Company Details
Table 85. Cipla Limited Business Overview
Table 86. Cipla Limited Anti-Neprilysin Product
Table 87. Cipla Limited Revenue in Anti-Neprilysin Business (2017-2022) & (US$ Million)
Table 88. Cipla Limited Recent Developments
Table 89. Oceanic Pharmachem Pvt. Ltd Company Details
Table 90. Oceanic Pharmachem Pvt. Ltd Business Overview
Table 91. Oceanic Pharmachem Pvt. Ltd Anti-Neprilysin Product
Table 92. Oceanic Pharmachem Pvt. Ltd Revenue in Anti-Neprilysin Business (2017-2022) & (US$ Million)
Table 93. Oceanic Pharmachem Pvt. Ltd Recent Developments
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-Neprilysin Market Share by Type: 2021 VS 2028
Figure 2. Sacubitril Features
Figure 3. TD-0714 Features
Figure 4. STR-324 Features
Figure 5. PL-265 Features
Figure 6. LHW-090 Features
Figure 7. Global Anti-Neprilysin Market Share by Application: 2021 VS 2028
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Anti-Neprilysin Report Years Considered
Figure 12. Global Anti-Neprilysin Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Anti-Neprilysin Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Anti-Neprilysin Market Share by Region: 2021 VS 2028
Figure 15. Global Anti-Neprilysin Market Share by Players in 2021
Figure 16. Global Top Anti-Neprilysin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Neprilysin as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Anti-Neprilysin Revenue in 2021
Figure 18. North America Anti-Neprilysin Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Anti-Neprilysin Market Size Market Share by Type (2017-2028)
Figure 20. North America Anti-Neprilysin Market Size Market Share by Application (2017-2028)
Figure 21. North America Anti-Neprilysin Market Size Share by Country (2017-2028)
Figure 22. United States Anti-Neprilysin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Anti-Neprilysin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Anti-Neprilysin Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Anti-Neprilysin Market Size Market Share by Type (2017-2028)
Figure 26. Europe Anti-Neprilysin Market Size Market Share by Application (2017-2028)
Figure 27. Europe Anti-Neprilysin Market Size Share by Country (2017-2028)
Figure 28. Germany Anti-Neprilysin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Anti-Neprilysin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Anti-Neprilysin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Anti-Neprilysin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Anti-Neprilysin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Anti-Neprilysin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Anti-Neprilysin Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Anti-Neprilysin Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Anti-Neprilysin Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Anti-Neprilysin Market Size Share by Region (2017-2028)
Figure 38. China Anti-Neprilysin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Anti-Neprilysin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Anti-Neprilysin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Anti-Neprilysin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Anti-Neprilysin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Anti-Neprilysin Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Anti-Neprilysin Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Anti-Neprilysin Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Anti-Neprilysin Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Anti-Neprilysin Market Size Share by Country (2017-2028)
Figure 48. Mexico Anti-Neprilysin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Anti-Neprilysin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Anti-Neprilysin Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Anti-Neprilysin Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Anti-Neprilysin Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Anti-Neprilysin Market Size Share by Country (2017-2028)
Figure 54. Turkey Anti-Neprilysin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Anti-Neprilysin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Anti-Neprilysin Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Bioprojet SCR Revenue Growth Rate in Anti-Neprilysin Business (2017-2022)
Figure 58. Novartis International AG Revenue Growth Rate in Anti-Neprilysin Business (2017-2022)
Figure 59. Pharmaleads SA Revenue Growth Rate in Anti-Neprilysin Business (2017-2022)
Figure 60. Theravance Biopharma Inc. Revenue Growth Rate in Anti-Neprilysin Business (2017-2022)
Figure 61. Cipla Limited Revenue Growth Rate in Anti-Neprilysin Business (2017-2022)
Figure 62. Oceanic Pharmachem Pvt. Ltd Revenue Growth Rate in Anti-Neprilysin Business (2017-2022)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount